CDMO Blog

close

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant
CDMOs: The Good, the Great and the Exceptional (and How to Tell the Difference)
What is a Bioreactor and How is it Used in Cell and Gene Therapy?
04 Mar 2021

5 Considerations for Scaling-Up PSC-Derived Cell Therapies

A core regenerative medicine approach is cell replacement for the repa...

20 Jan 2021

Solving the Technical Challenges in Gene Editing of Induced Pluripotent Stem Cells

In a previous post we provided an overview of induced pluripotent stem...

Tell us what you thought about this post.